Medplus Health ServicesNSE:MEDPLUS -0.83%85 ROE % is 12.96% as of Mar. 2026, which is 96% above its 10-year median of 6.60. GuruFocus rates NSE:MEDPLUS with a GF Score™ of 85/100 and a GF Value™ of ₹951.53 (Modestly Undervalued). Among 625 Healthcare Providers & Services companies, Medplus Health Services ranks better than 68.8% on this metric.
The historical rank and industry rank for Medplus Health Services's ROE % or its related term are showing as below:
NSE:MEDPLUS'
s ROE % Range Over the Past 10 Years
Min: 0.53 Med: 6.6 Max: 11.85
Current: 11.85
During the past 8 years, Medplus Health Services's highest ROE % was 11.85%. The lowest was 0.53%. And the median was 6.60%.
NSE:MEDPLUS's ROE % is ranked better than 68.8% of 625
companies
in the Healthcare Providers & Services industry
Industry Median: 5.84
vs NSE:MEDPLUS: 11.85
Medplus Health Services (NSE:MEDPLUS) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medplus Health Services ROE % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Medplus Health Services's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medplus Health Services ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medplus Health Services's ROE % distribution charts can be found below:
* The bar in red indicates where Medplus Health Services's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Medplus Health Services (NSE:MEDPLUS) has a ROE % of 12.96% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Medplus Health Services and its competitors. This is 96% above median its historical median of 6.60. Over the past decade, Medplus Health Services' ROE % has ranged from 0.53 to 11.85. According to the industry distribution chart, Medplus Health Services ranks #195 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 31.2%.
Is Medplus Health Services' ROE % too high?
Medplus Health Services' current ROE % of 12.96% is 96% above median its 10-year median of 6.60. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 11.85. The Healthcare Providers & Services industry median ROE % is 5.84. Medplus Health Services' value of 12.96% is 121.9% above this industry median. Based on the distribution chart, Medplus Health Services ranks #195 out of 625 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medplus Health Services has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medplus Health Services' ROE % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Medplus Health Services ranks #195 out of 625 companies for ROE %. This puts Medplus Health Services in the upper half of its industry. The industry median ROE % is 5.84. Medplus Health Services' value of 12.96% is 121.9% above this benchmark. Historically, Medplus Health Services' own ROE % has ranged from 0.53 to 11.85 over the past decade. While the company's 10-year median is 6.60 vs. the industry median of 5.84, Medplus Health Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medplus Health Services's current ROE % of 12.96% is 121.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Medplus Health Services and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medplus Health Services's current ROE % is 12.96%, which is 96% above median its own 10-year median of 6.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medplus Health Services stock overvalued right now?
Based on GuruFocus' analysis, Medplus Health Services (NSE:MEDPLUS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹951.53, compared to a current price of ₹835.00 — trading 12.2% below its estimated fair value. The current ROE % is 12.96%, which is 96% above median its 10-year median of 6.60 and 121.9% above the Healthcare Providers & Services industry median of 5.84. Medplus Health Services' overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Medplus Health Services (NSE:MEDPLUS), the current ROE % is 12.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?
Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued.
The current stock price of ₹835.00 is trading 12.2% below its estimated GF Value™ of ₹951.53.
GuruFocus considers Medplus Health Services to be Modestly Undervalued.
Key valuation signals for NSE:MEDPLUS:
ROE %: 12.96% (96% above median its 10-year median of 6.60)
GF Value™: ₹951.53 vs. price of ₹835.00 (12.2% below fair value)
Industry Position: 121.9% above the Healthcare Providers & Services median (#195 of 625)
No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
85GF Score
Get the complete analysis for NSE:MEDPLUS
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDPLUS has been successfully added to your 
